These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 35693394)

  • 1. Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention.
    Spivak I; Elinav E
    Hepatobiliary Surg Nutr; 2022 Jun; 11(3):492-494. PubMed ID: 35693394
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-Alcoholic Fatty Liver Disease in HIV Infection.
    Macías J; Pineda JA; Real LM
    AIDS Rev; 2017; 19(1):35-46. PubMed ID: 28182612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin?
    Völzke H
    World J Gastroenterol; 2012 Jul; 18(27):3492-501. PubMed ID: 22826613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.
    Byrne CD
    Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction.
    Federico A; Dallio M; Masarone M; Persico M; Loguercio C
    Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4731-4741. PubMed ID: 27906428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review.
    Singh S; Osna NA; Kharbanda KK
    World J Gastroenterol; 2017 Sep; 23(36):6549-6570. PubMed ID: 29085205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD).
    Tasneem AA; Luck NH; Majid Z
    Trop Doct; 2018 Apr; 48(2):107-112. PubMed ID: 29145775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive association of nap duration with risk of non-alcoholic fatty liver disease in an occupational population in Guangdong Province, China: a cross-sectional study.
    Hong C; Wu C; Ma P; Cui H; Chen L; Li R; Li Q; Zeng L; Liao S; Xiao L; Liu L; Li W
    BMC Gastroenterol; 2022 Apr; 22(1):185. PubMed ID: 35413791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups.
    ; Lonardo A; Bellentani S; Argo CK; Ballestri S; Byrne CD; Caldwell SH; Cortez-Pinto H; Grieco A; Machado MV; Miele L; Targher G
    Dig Liver Dis; 2015 Dec; 47(12):997-1006. PubMed ID: 26454786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations Among Methylene Tetrahydrofolate Reductase rs1801133
    Hao X; Ma C; Xiang T; Ou L; Zeng Q
    Front Genet; 2021; 12():568398. PubMed ID: 33679874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal analysis of risk of non-alcoholic fatty liver disease in adulthood.
    Cuthbertson DJ; Brown E; Koskinen J; Magnussen CG; Hutri-Kähönen N; Sabin M; Tossavainen P; Jokinen E; Laitinen T; Viikari J; Raitakari OT; Juonala M
    Liver Int; 2019 Jun; 39(6):1147-1154. PubMed ID: 30347485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exposure to ambient air particulate matter and non-alcoholic fatty liver disease.
    Tarantino G; Capone D; Finelli C
    World J Gastroenterol; 2013 Jul; 19(25):3951-6. PubMed ID: 23840139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.
    Souza MR; Diniz Mde F; Medeiros-Filho JE; Araújo MS
    Arq Gastroenterol; 2012; 49(1):89-96. PubMed ID: 22481692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that predict the occurrence of and recovery from non-alcoholic fatty liver disease after pancreatoduodenectomy.
    Sato T; Matsuo Y; Shiga K; Morimoto M; Miyai H; Takeyama H
    Surgery; 2016 Aug; 160(2):318-30. PubMed ID: 27211602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea?
    Mirrakhimov AE
    Cardiovasc Diabetol; 2014 Jan; 13():29. PubMed ID: 24475948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD).
    Johnston MP; Patel J; Byrne CD
    Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease.
    Reilly NR; Lebwohl B; Hultcrantz R; Green PH; Ludvigsson JF
    J Hepatol; 2015 Jun; 62(6):1405-11. PubMed ID: 25617505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China.
    Yi M; Chen RP; Yang R; Chen H
    Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Helicobacter pylori and non-alcoholic fatty liver disease.
    Buzás GM
    Minerva Gastroenterol Dietol; 2020 Sep; 66(3):267-279. PubMed ID: 32724031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-alcoholic fatty liver disease pathogenesis: the present and the future.
    Petta S; Muratore C; Craxì A
    Dig Liver Dis; 2009 Sep; 41(9):615-25. PubMed ID: 19223251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.